HEADER TRANSPORT PROTEIN 10-JUL-23 8K11 TITLE SID1 TRANSMEMBRANE FAMILY MEMBER 2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: SID1 TRANSMEMBRANE FAMILY MEMBER 2; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SIDT2, CGI-40, PSEC0072, UNQ685/PRO1325; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS VIRAL PROTEIN-IMMUNE SYSTEM COMPLEX, TRANSPORT PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR H.GUO,C.QI,Y.LU,H.YANG,Y.ZHU,F.SUN,X.JI REVDAT 1 10-JUL-24 8K11 0 JRNL AUTH L.ZHENG,T.YANG,H.GUO,C.QI,Y.LU,H.XIAO,Y.GAO,Y.LIU,Y.YANG, JRNL AUTH 2 M.ZHOU,H.C.NGUYEN,Y.ZHU,F.SUN,C.Y.ZHANG,X.JI JRNL TITL CRYO-EM STRUCTURES OF HUMAN SID-1 TRANSMEMBRANE FAMILY JRNL TITL 2 PROTEINS AND IMPLICATIONS FOR THEIR LOW-PH-DEPENDENT RNA JRNL TITL 3 TRANSPORT ACTIVITY. JRNL REF CELL RES. V. 34 80 2024 JRNL REFN ISSN 1001-0602 JRNL PMID 37932445 JRNL DOI 10.1038/S41422-023-00893-1 REMARK 2 REMARK 2 RESOLUTION. 3.30 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 3.300 REMARK 3 NUMBER OF PARTICLES : 187510 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 8K11 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 19-JUL-23. REMARK 100 THE DEPOSITION ID IS D_1300039101. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : HUMAN SID1 TRANSMEMBRANE FAMILY REMARK 245 MEMBER 2 (SIDT2) HOMODIMER, ECD REMARK 245 FOCUSED REFINEMENT REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.50 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN REMARK 245 DETECTOR TYPE : GATAN K3 (6K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1200.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2000.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : SPOT SCAN REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, O, C, D, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 2 REMARK 465 LYS A 3 REMARK 465 ALA A 4 REMARK 465 ASN A 5 REMARK 465 LEU A 6 REMARK 465 LEU A 7 REMARK 465 VAL A 8 REMARK 465 LEU A 9 REMARK 465 LEU A 10 REMARK 465 CYS A 11 REMARK 465 ALA A 12 REMARK 465 LEU A 13 REMARK 465 ALA A 14 REMARK 465 ALA A 15 REMARK 465 ALA A 16 REMARK 465 ASP A 17 REMARK 465 ALA A 18 REMARK 465 HIS A 19 REMARK 465 LEU A 20 REMARK 465 GLY A 21 REMARK 465 VAL A 22 REMARK 465 LEU A 23 REMARK 465 GLY A 24 REMARK 465 MET B 2 REMARK 465 LYS B 3 REMARK 465 ALA B 4 REMARK 465 ASN B 5 REMARK 465 LEU B 6 REMARK 465 LEU B 7 REMARK 465 VAL B 8 REMARK 465 LEU B 9 REMARK 465 LEU B 10 REMARK 465 CYS B 11 REMARK 465 ALA B 12 REMARK 465 LEU B 13 REMARK 465 ALA B 14 REMARK 465 ALA B 15 REMARK 465 ALA B 16 REMARK 465 ASP B 17 REMARK 465 ALA B 18 REMARK 465 HIS B 19 REMARK 465 LEU B 20 REMARK 465 GLY B 21 REMARK 465 VAL B 22 REMARK 465 LEU B 23 REMARK 465 GLY B 24 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 31 CG CD CE NZ REMARK 470 LYS A 111 CG CD CE NZ REMARK 470 LYS A 193 CG CD CE NZ REMARK 470 LYS A 227 CG CD CE NZ REMARK 470 GLU A 252 CG CD OE1 OE2 REMARK 470 GLN A 254 CG CD OE1 NE2 REMARK 470 LYS B 31 CG CD CE NZ REMARK 470 LYS B 111 CG CD CE NZ REMARK 470 LYS B 193 CG CD CE NZ REMARK 470 LYS B 227 CG CD CE NZ REMARK 470 GLU B 252 CG CD OE1 OE2 REMARK 470 GLN B 254 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 153 57.12 -94.54 REMARK 500 ASP B 153 57.11 -94.54 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-36783 RELATED DB: EMDB REMARK 900 TO BE PUBLISHED DBREF 8K11 A 19 287 UNP Q8NBJ9 SIDT2_HUMAN 19 287 DBREF 8K11 B 19 287 UNP Q8NBJ9 SIDT2_HUMAN 19 287 SEQADV 8K11 MET A 2 UNP Q8NBJ9 INITIATING METHIONINE SEQADV 8K11 LYS A 3 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA A 4 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ASN A 5 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU A 6 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU A 7 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 VAL A 8 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU A 9 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU A 10 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 CYS A 11 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA A 12 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU A 13 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA A 14 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA A 15 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA A 16 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ASP A 17 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA A 18 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 MET B 2 UNP Q8NBJ9 INITIATING METHIONINE SEQADV 8K11 LYS B 3 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA B 4 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ASN B 5 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU B 6 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU B 7 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 VAL B 8 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU B 9 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU B 10 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 CYS B 11 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA B 12 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 LEU B 13 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA B 14 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA B 15 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA B 16 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ASP B 17 UNP Q8NBJ9 EXPRESSION TAG SEQADV 8K11 ALA B 18 UNP Q8NBJ9 EXPRESSION TAG SEQRES 1 A 286 MET LYS ALA ASN LEU LEU VAL LEU LEU CYS ALA LEU ALA SEQRES 2 A 286 ALA ALA ASP ALA HIS LEU GLY VAL LEU GLY PRO LYS ASN SEQRES 3 A 286 VAL SER GLN LYS ASP ALA GLU PHE GLU ARG THR TYR VAL SEQRES 4 A 286 ASP GLU VAL ASN SER GLU LEU VAL ASN ILE TYR THR PHE SEQRES 5 A 286 ASN HIS THR VAL THR ARG ASN ARG THR GLU GLY VAL ARG SEQRES 6 A 286 VAL SER VAL ASN VAL LEU ASN LYS GLN LYS GLY ALA PRO SEQRES 7 A 286 LEU LEU PHE VAL VAL ARG GLN LYS GLU ALA VAL VAL SER SEQRES 8 A 286 PHE GLN VAL PRO LEU ILE LEU ARG GLY MET PHE GLN ARG SEQRES 9 A 286 LYS TYR LEU TYR GLN LYS VAL GLU ARG THR LEU CYS GLN SEQRES 10 A 286 PRO PRO THR LYS ASN GLU SER GLU ILE GLN PHE PHE TYR SEQRES 11 A 286 VAL ASP VAL SER THR LEU SER PRO VAL ASN THR THR TYR SEQRES 12 A 286 GLN LEU ARG VAL SER ARG MET ASP ASP PHE VAL LEU ARG SEQRES 13 A 286 THR GLY GLU GLN PHE SER PHE ASN THR THR ALA ALA GLN SEQRES 14 A 286 PRO GLN TYR PHE LYS TYR GLU PHE PRO GLU GLY VAL ASP SEQRES 15 A 286 SER VAL ILE VAL LYS VAL THR SER ASN LYS ALA PHE PRO SEQRES 16 A 286 CYS SER VAL ILE SER ILE GLN ASP VAL LEU CYS PRO VAL SEQRES 17 A 286 TYR ASP LEU ASP ASN ASN VAL ALA PHE ILE GLY MET TYR SEQRES 18 A 286 GLN THR MET THR LYS LYS ALA ALA ILE THR VAL GLN ARG SEQRES 19 A 286 LYS ASP PHE PRO SER ASN SER PHE TYR VAL VAL VAL VAL SEQRES 20 A 286 VAL LYS THR GLU ASP GLN ALA CYS GLY GLY SER LEU PRO SEQRES 21 A 286 PHE TYR PRO PHE ALA GLU ASP GLU PRO VAL ASP GLN GLY SEQRES 22 A 286 HIS ARG GLN LYS THR LEU SER VAL LEU VAL SER GLN ALA SEQRES 1 B 286 MET LYS ALA ASN LEU LEU VAL LEU LEU CYS ALA LEU ALA SEQRES 2 B 286 ALA ALA ASP ALA HIS LEU GLY VAL LEU GLY PRO LYS ASN SEQRES 3 B 286 VAL SER GLN LYS ASP ALA GLU PHE GLU ARG THR TYR VAL SEQRES 4 B 286 ASP GLU VAL ASN SER GLU LEU VAL ASN ILE TYR THR PHE SEQRES 5 B 286 ASN HIS THR VAL THR ARG ASN ARG THR GLU GLY VAL ARG SEQRES 6 B 286 VAL SER VAL ASN VAL LEU ASN LYS GLN LYS GLY ALA PRO SEQRES 7 B 286 LEU LEU PHE VAL VAL ARG GLN LYS GLU ALA VAL VAL SER SEQRES 8 B 286 PHE GLN VAL PRO LEU ILE LEU ARG GLY MET PHE GLN ARG SEQRES 9 B 286 LYS TYR LEU TYR GLN LYS VAL GLU ARG THR LEU CYS GLN SEQRES 10 B 286 PRO PRO THR LYS ASN GLU SER GLU ILE GLN PHE PHE TYR SEQRES 11 B 286 VAL ASP VAL SER THR LEU SER PRO VAL ASN THR THR TYR SEQRES 12 B 286 GLN LEU ARG VAL SER ARG MET ASP ASP PHE VAL LEU ARG SEQRES 13 B 286 THR GLY GLU GLN PHE SER PHE ASN THR THR ALA ALA GLN SEQRES 14 B 286 PRO GLN TYR PHE LYS TYR GLU PHE PRO GLU GLY VAL ASP SEQRES 15 B 286 SER VAL ILE VAL LYS VAL THR SER ASN LYS ALA PHE PRO SEQRES 16 B 286 CYS SER VAL ILE SER ILE GLN ASP VAL LEU CYS PRO VAL SEQRES 17 B 286 TYR ASP LEU ASP ASN ASN VAL ALA PHE ILE GLY MET TYR SEQRES 18 B 286 GLN THR MET THR LYS LYS ALA ALA ILE THR VAL GLN ARG SEQRES 19 B 286 LYS ASP PHE PRO SER ASN SER PHE TYR VAL VAL VAL VAL SEQRES 20 B 286 VAL LYS THR GLU ASP GLN ALA CYS GLY GLY SER LEU PRO SEQRES 21 B 286 PHE TYR PRO PHE ALA GLU ASP GLU PRO VAL ASP GLN GLY SEQRES 22 B 286 HIS ARG GLN LYS THR LEU SER VAL LEU VAL SER GLN ALA HET NAG O 1 14 HET NAG O 2 14 HET NAG C 1 14 HET NAG C 2 14 HET NAG D 1 14 HET NAG D 2 14 HET NAG E 1 14 HET NAG E 2 14 HET NAG A 301 14 HET NAG A 302 14 HET NAG A 303 14 HET NAG A 304 14 HET NAG B 301 14 HET NAG B 302 14 HET NAG B 303 14 HET NAG B 304 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 3 NAG 16(C8 H15 N O6) SHEET 1 AA1 5 ASN A 27 LYS A 31 0 SHEET 2 AA1 5 LEU A 47 THR A 58 1 O VAL A 48 N SER A 29 SHEET 3 AA1 5 SER A 125 SER A 135 -1 O GLN A 128 N HIS A 55 SHEET 4 AA1 5 LEU A 80 ARG A 85 -1 N LEU A 81 O SER A 135 SHEET 5 AA1 5 VAL A 90 VAL A 95 -1 O PHE A 93 N PHE A 82 SHEET 1 AA2 4 TYR A 39 VAL A 43 0 SHEET 2 AA2 4 THR A 142 ARG A 150 -1 O LEU A 146 N TYR A 39 SHEET 3 AA2 4 VAL A 65 VAL A 71 -1 N ARG A 66 O SER A 149 SHEET 4 AA2 4 LYS A 111 THR A 115 -1 O ARG A 114 N VAL A 67 SHEET 1 AA3 3 LEU A 97 ARG A 100 0 SHEET 2 AA3 3 LYS A 106 TYR A 109 -1 O TYR A 107 N LEU A 99 SHEET 3 AA3 3 VAL A 271 ASP A 272 1 O VAL A 271 N LYS A 106 SHEET 1 AA4 4 PHE A 162 THR A 166 0 SHEET 2 AA4 4 LYS A 278 GLN A 286 -1 O LEU A 280 N PHE A 164 SHEET 3 AA4 4 SER A 184 THR A 190 -1 N LYS A 188 O LEU A 283 SHEET 4 AA4 4 LYS A 228 GLN A 234 -1 O ILE A 231 N VAL A 187 SHEET 1 AA5 4 GLN A 172 GLU A 177 0 SHEET 2 AA5 4 SER A 242 VAL A 249 -1 O VAL A 245 N PHE A 174 SHEET 3 AA5 4 SER A 198 ASP A 204 -1 N SER A 201 O VAL A 246 SHEET 4 AA5 4 MET A 221 MET A 225 -1 O GLN A 223 N ILE A 200 SHEET 1 AA6 5 ASN B 27 LYS B 31 0 SHEET 2 AA6 5 LEU B 47 THR B 58 1 O VAL B 48 N SER B 29 SHEET 3 AA6 5 SER B 125 SER B 135 -1 O GLN B 128 N HIS B 55 SHEET 4 AA6 5 LEU B 80 ARG B 85 -1 N LEU B 81 O SER B 135 SHEET 5 AA6 5 VAL B 90 VAL B 95 -1 O PHE B 93 N PHE B 82 SHEET 1 AA7 4 TYR B 39 VAL B 43 0 SHEET 2 AA7 4 THR B 142 ARG B 150 -1 O LEU B 146 N TYR B 39 SHEET 3 AA7 4 VAL B 65 VAL B 71 -1 N ARG B 66 O SER B 149 SHEET 4 AA7 4 LYS B 111 THR B 115 -1 O ARG B 114 N VAL B 67 SHEET 1 AA8 3 LEU B 97 ARG B 100 0 SHEET 2 AA8 3 LYS B 106 TYR B 109 -1 O TYR B 107 N LEU B 99 SHEET 3 AA8 3 VAL B 271 ASP B 272 1 O VAL B 271 N LYS B 106 SHEET 1 AA9 4 PHE B 162 THR B 166 0 SHEET 2 AA9 4 LYS B 278 GLN B 286 -1 O LEU B 280 N PHE B 164 SHEET 3 AA9 4 SER B 184 THR B 190 -1 N LYS B 188 O LEU B 283 SHEET 4 AA9 4 LYS B 228 GLN B 234 -1 O ILE B 231 N VAL B 187 SHEET 1 AB1 4 GLN B 172 GLU B 177 0 SHEET 2 AB1 4 SER B 242 VAL B 249 -1 O VAL B 245 N PHE B 174 SHEET 3 AB1 4 SER B 198 ASP B 204 -1 N SER B 201 O VAL B 246 SHEET 4 AB1 4 MET B 221 MET B 225 -1 O GLN B 223 N ILE B 200 SSBOND 1 CYS A 117 CYS A 207 1555 1555 2.03 SSBOND 2 CYS A 197 CYS A 256 1555 1555 2.03 SSBOND 3 CYS B 117 CYS B 207 1555 1555 2.03 SSBOND 4 CYS B 197 CYS B 256 1555 1555 2.03 LINK ND2 ASN A 27 C1 NAG A 301 1555 1555 1.45 LINK ND2 ASN A 54 C1 NAG O 1 1555 1555 1.44 LINK ND2 ASN A 60 C1 NAG A 302 1555 1555 1.44 LINK ND2 ASN A 123 C1 NAG A 303 1555 1555 1.44 LINK ND2 ASN A 141 C1 NAG A 304 1555 1555 1.45 LINK ND2 ASN A 165 C1 NAG D 1 1555 1555 1.44 LINK ND2 ASN B 27 C1 NAG B 301 1555 1555 1.45 LINK ND2 ASN B 54 C1 NAG C 1 1555 1555 1.44 LINK ND2 ASN B 60 C1 NAG B 302 1555 1555 1.44 LINK ND2 ASN B 123 C1 NAG B 303 1555 1555 1.45 LINK ND2 ASN B 141 C1 NAG B 304 1555 1555 1.44 LINK ND2 ASN B 165 C1 NAG E 1 1555 1555 1.44 LINK O4 NAG O 1 C1 NAG O 2 1555 1555 1.44 LINK O4 NAG C 1 C1 NAG C 2 1555 1555 1.44 LINK O4 NAG D 1 C1 NAG D 2 1555 1555 1.44 LINK O4 NAG E 1 C1 NAG E 2 1555 1555 1.44 CISPEP 1 VAL A 95 PRO A 96 0 0.97 CISPEP 2 PHE A 195 PRO A 196 0 5.23 CISPEP 3 CYS A 207 PRO A 208 0 -0.63 CISPEP 4 VAL B 95 PRO B 96 0 1.18 CISPEP 5 PHE B 195 PRO B 196 0 5.12 CISPEP 6 CYS B 207 PRO B 208 0 -0.76 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000